SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-040993
Filing Date
2021-06-16
Accepted
2021-06-16 17:18:58
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4007
  Complete submission text file 0001209191-21-040993.txt   5482
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400 CAMBRIDGE MA 02139
Business Address
Beckman Daniella (Reporting) CIK: 0001513422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38550 | Film No.: 211022369

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Issuer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)